» Articles » PMID: 34017238

Examination of BDNF Treatment on BACE1 Activity and Acute Exercise on Brain BDNF Signaling

Overview
Specialty Cell Biology
Date 2021 May 21
PMID 34017238
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Perturbations in metabolism results in the accumulation of beta-amyloid peptides, which is a pathological feature of Alzheimer's disease. Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) is the rate limiting enzyme responsible for beta-amyloid production. Obesogenic diets increase BACE1 while exercise reduces BACE1 activity, although the mechanisms are unknown. Brain-derived neurotropic factor (BDNF) is an exercise inducible neurotrophic factor, however, it is unknown if BDNF is related to the effects of exercise on BACE1. The purpose of this study was to determine the direct effect of BDNF on BACE1 activity and to examine neuronal pathways induced by exercise. C57BL/6J male mice were assigned to either a low ( = 36) or high fat diet ( = 36) for 10 weeks. To determine the direct effect of BDNF on BACE1, a subset of mice (low fat diet = 12 and high fat diet = 12) were used for an explant experiment where the brain tissue was directly treated with BDNF (100 ng/ml) for 30 min. To examine neuronal pathways activated with exercise, mice remained sedentary ( = 12) or underwent an acute bout of treadmill running at 15 m/min with a 5% incline for 120 min ( = 12). The prefrontal cortex and hippocampus were collected 2-h post-exercise. Direct treatment with BDNF resulted in reductions in BACE1 activity in the prefrontal cortex ( < 0.05), but not the hippocampus. The high fat diet reduced BDNF content in the hippocampus; however, the acute bout of exercise increased BDNF in the prefrontal cortex ( < 0.05). These novel findings demonstrate the region specific differences in exercise induced BDNF in lean and obese mice and show that BDNF can reduce BACE1 activity, independent of other exercise-induced alterations. This work demonstrates a previously unknown link between BDNF and BACE1 regulation.

Citing Articles

Impact of physical exercise on the regulation of brain-derived neurotrophic factor in people with neurodegenerative diseases.

Romero Garavito A, Diaz Martinez V, Juarez Cortes E, Negrete Diaz J, Montilla Rodriguez L Front Neurol. 2025; 15:1505879.

PMID: 39935805 PMC: 11810746. DOI: 10.3389/fneur.2024.1505879.


Brain-derived neurotrophic factor drives muscle adaptation similar to aerobic training in mice.

Brown A, Marko A, Marko D, Baranowski B, Silvera S, Finch M FASEB J. 2025; 39(2):e70321.

PMID: 39853792 PMC: 11760663. DOI: 10.1096/fj.202402421R.


The Role of Central and Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker of Anorexia Nervosa Reconceptualized as a Metabo-Psychiatric Disorder.

Cao J, Gorwood P, Ramoz N, Viltart O Nutrients. 2024; 16(16).

PMID: 39203753 PMC: 11357464. DOI: 10.3390/nu16162617.


Examination of Akt and GSK3β in BDNF-mediated reductions in BACE1 activity in neuronal cells.

Baranowski B, Mohammad A, LeBlanc P, Fajardo V, MacPherson R Physiol Rep. 2024; 12(16):e70001.

PMID: 39161054 PMC: 11333542. DOI: 10.14814/phy2.70001.


Exercise mimetics: a novel strategy to combat neuroinflammation and Alzheimer's disease.

Zhao R J Neuroinflammation. 2024; 21(1):40.

PMID: 38308368 PMC: 10837901. DOI: 10.1186/s12974-024-03031-9.


References
1.
Rosenfeld C, Ferguson S . Barnes maze testing strategies with small and large rodent models. J Vis Exp. 2014; (84):e51194. PMC: 4140524. DOI: 10.3791/51194. View

2.
Hardy J, Higgins G . Alzheimer's disease: the amyloid cascade hypothesis. Science. 1992; 256(5054):184-5. DOI: 10.1126/science.1566067. View

3.
Profenno L, Porsteinsson A, Faraone S . Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol Psychiatry. 2009; 67(6):505-12. DOI: 10.1016/j.biopsych.2009.02.013. View

4.
Candeias E, Duarte A, Carvalho C, Correia S, Cardoso S, Santos R . The impairment of insulin signaling in Alzheimer's disease. IUBMB Life. 2012; 64(12):951-7. DOI: 10.1002/iub.1098. View

5.
Gandy S . The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J Clin Invest. 2005; 115(5):1121-9. PMC: 1087184. DOI: 10.1172/JCI25100. View